Bio-Techne (TECH) Net Cash Flow (2009 - 2026)
Bio-Techne's quarterly Net Cash Flow came in at $38.1 million in Q1 2026, up 206.51% year-on-year from $12.4 million in Q1 2025, and up 38.63% quarter-over-quarter from $27.5 million in Q4 2025.
Bio-Techne has reported Net Cash Flow for 18 years, with the latest figure at $38.1 million in Q1 2026.
- For the quarter ending Q1 2026, Net Cash Flow rose 206.51% year-over-year to $38.1 million; the trailing twelve-month figure through Mar 2026 stood at $57.8 million (up 1967.26% YoY), and the FY2025 full-year result was -$1.5 million, up 94.21% from the prior year.
- Net Cash Flow for Q1 2026 stood at $38.1 million, up from $27.5 million in the prior quarter.
- The five-year high for Net Cash Flow was $54.4 million in Q2 2023, with the low at -$46.9 million in Q1 2022.
- Average Net Cash Flow over 5 years is $264000.0, with a median of $4.6 million recorded in 2022.
- Year-over-year, Net Cash Flow plunged 606.1% in 2023 and surged 708.09% in 2025.
- Tracing TECH's Net Cash Flow over 5 years: stood at -$7.9 million in 2022, then slumped by 177.2% to -$22.0 million in 2023, then surged by 79.4% to -$4.5 million in 2024, then surged by 708.09% to $27.5 million in 2025, then soared by 38.63% to $38.1 million in 2026.
- The last three Net Cash Flow figures came in at $38.1 million (Q1 2026), $27.5 million (Q4 2025), and -$16.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 625.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 457.40 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -152.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 60.68 Mn |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn | 38.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.13 Mn |
| Mar 31, 2026 | 38.13 Mn |
| Dec 31, 2025 | 27.50 Mn |
| Dec 31, 2025 | 27.50 Mn |
| Sep 30, 2025 | -16.01 Mn |
| Sep 30, 2025 | -16.01 Mn |
| Jun 30, 2025 | 8.16 Mn |
| Jun 30, 2025 | 8.16 Mn |
| Mar 31, 2025 | -35.80 Mn |
| Mar 31, 2025 | -35.80 Mn |
| Dec 31, 2024 | -4.52 Mn |
| Dec 31, 2024 | -4.52 Mn |
| Sep 30, 2024 | 30.63 Mn |
| Sep 30, 2024 | 30.63 Mn |
| Jun 30, 2024 | 6.59 Mn |
| Jun 30, 2024 | 6.59 Mn |
| Mar 31, 2024 | 12.13 Mn |
| Mar 31, 2024 | 12.13 Mn |
| Dec 31, 2023 | -21.95 Mn |
| Dec 31, 2023 | -21.95 Mn |
| Sep 30, 2023 | -23.22 Mn |
| Sep 30, 2023 | -23.22 Mn |
| Jun 30, 2023 | 54.42 Mn |
| Jun 30, 2023 | 54.42 Mn |
| Mar 31, 2023 | -39.72 Mn |
| Mar 31, 2023 | -39.72 Mn |
| Dec 31, 2022 | -7.92 Mn |
| Dec 31, 2022 | -7.92 Mn |
| Sep 30, 2022 | 4.59 Mn |
| Sep 30, 2022 | 4.59 Mn |
| Jun 30, 2022 | 18.42 Mn |
| Jun 30, 2022 | 18.42 Mn |
| Mar 31, 2022 | -46.93 Mn |
| Mar 31, 2022 | -46.93 Mn |
| Dec 31, 2021 | 12.45 Mn |
| Dec 31, 2021 | 12.45 Mn |
| Sep 30, 2021 | 1.63 Mn |
| Sep 30, 2021 | 1.63 Mn |
| Jun 30, 2021 | 12.81 Mn |
| Jun 30, 2021 | 12.81 Mn |
| Mar 31, 2021 | 19.77 Mn |
| Mar 31, 2021 | 19.77 Mn |
| Dec 31, 2020 | -9.41 Mn |
| Dec 31, 2020 | -9.41 Mn |
| Sep 30, 2020 | 22.94 Mn |
| Sep 30, 2020 | 22.94 Mn |
| Jun 30, 2020 | -10.40 Mn |
| Jun 30, 2020 | -10.40 Mn |
| Mar 31, 2020 | 51.04 Mn |
| Mar 31, 2020 | 51.04 Mn |
| Dec 31, 2019 | 6.69 Mn |
| Dec 31, 2019 | 6.69 Mn |
| Sep 30, 2019 | 1.19 Mn |
| Sep 30, 2019 | 1.19 Mn |
| Jun 30, 2019 | 5.73 Mn |
| Jun 30, 2019 | 5.73 Mn |
| Mar 31, 2019 | 7.88 Mn |
| Mar 31, 2019 | 7.88 Mn |
| Dec 31, 2018 | -8.28 Mn |
| Dec 31, 2018 | -8.28 Mn |
| Sep 30, 2018 | -26.13 Mn |
| Sep 30, 2018 | -26.13 Mn |
| Jun 30, 2018 | 39.98 Mn |
| Jun 30, 2018 | 39.98 Mn |
| Mar 31, 2018 | -37.23 Mn |
| Mar 31, 2018 | -37.23 Mn |
| Dec 31, 2017 | 48.39 Mn |
| Dec 31, 2017 | 48.39 Mn |
| Sep 30, 2017 | -18.66 Mn |
| Sep 30, 2017 | -18.66 Mn |
| Jun 30, 2017 | 29.50 Mn |
| Jun 30, 2017 | 29.50 Mn |
| Mar 31, 2017 | 504,000.00 |
| Mar 31, 2017 | 504,000.00 |
| Dec 31, 2016 | -9.04 Mn |
| Dec 31, 2016 | -9.04 Mn |
| Sep 30, 2016 | 554,000.00 |
| Sep 30, 2016 | 554,000.00 |
| Jun 30, 2016 | 696,000.00 |
| Jun 30, 2016 | 696,000.00 |
| Mar 31, 2016 | 3.62 Mn |
| Mar 31, 2016 | 3.62 Mn |
| Dec 31, 2015 | 20.37 Mn |
| Dec 31, 2015 | 20.37 Mn |
| Sep 30, 2015 | -11.46 Mn |
| Sep 30, 2015 | -11.46 Mn |
| Jun 30, 2015 | -54.06 Mn |
| Jun 30, 2015 | -54.06 Mn |
| Mar 31, 2015 | 16.63 Mn |
| Mar 31, 2015 | 16.63 Mn |
| Dec 31, 2014 | -1.86 Mn |
| Dec 31, 2014 | -1.86 Mn |
| Sep 30, 2014 | -216.57 Mn |
| Sep 30, 2014 | -216.57 Mn |
| Jun 30, 2014 | 193.60 Mn |
| Jun 30, 2014 | 193.60 Mn |
| Mar 31, 2014 | 24.94 Mn |
| Mar 31, 2014 | 24.94 Mn |
| Dec 31, 2013 | 13.56 Mn |
| Dec 31, 2013 | 13.56 Mn |
| Sep 30, 2013 | -82.45 Mn |
| Sep 30, 2013 | -82.45 Mn |
| Jun 30, 2013 | 12.64 Mn |
| Jun 30, 2013 | 12.64 Mn |
| Mar 31, 2013 | 10.45 Mn |
| Mar 31, 2013 | 10.45 Mn |
| Dec 31, 2012 | 11.99 Mn |
| Dec 31, 2012 | 11.99 Mn |
| Sep 30, 2012 | 12.60 Mn |
| Sep 30, 2012 | 12.60 Mn |
| Jun 30, 2012 | 22.43 Mn |
| Jun 30, 2012 | 22.43 Mn |
| Mar 31, 2012 | 13.41 Mn |
| Mar 31, 2012 | 13.41 Mn |
| Dec 31, 2011 | 2.18 Mn |
| Dec 31, 2011 | 2.18 Mn |
| Sep 30, 2011 | 2.43 Mn |
| Sep 30, 2011 | 2.43 Mn |
| Jun 30, 2011 | -82.55 Mn |
| Jun 30, 2011 | -82.55 Mn |
| Mar 31, 2011 | 19.74 Mn |
| Mar 31, 2011 | 19.74 Mn |
| Dec 31, 2010 | 22.10 Mn |
| Dec 31, 2010 | 22.10 Mn |
| Sep 30, 2010 | 17.43 Mn |
| Sep 30, 2010 | 17.43 Mn |
| Jun 30, 2010 | -12.28 Mn |
| Jun 30, 2010 | -12.28 Mn |
| Mar 31, 2010 | -77.93 Mn |
| Mar 31, 2010 | -77.93 Mn |
| Dec 31, 2009 | 19.78 Mn |
| Dec 31, 2009 | 19.78 Mn |
| Sep 30, 2009 | 16.56 Mn |
| Sep 30, 2009 | 16.56 Mn |